Kd Dd Quote - 0M5A | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
UK
LSE
Kd Dd (0M5A) Share Price

Kd Dd (0M5A)

80.00

0.00

(0.00%)

Closed January 05 10:30AM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

80.00

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

80.00 52 Week Range 80.00

Market Cap

Previous Close

80.00

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

0.00

Shares Outstanding

156,000

Dividend Yield

-

PE Ratio

1.81

Earnings Per Share (EPS)

44.12

Revenue

79.64M

Net Profit

6.88M

Sector

Finance Services

Industry

Finance Services

Website

www.kd-fd.si

Headquarters

Ljubljana, Svn

Founded

-

Kd Dd is listed in the Finance Services sector of the London Stock Exchange with ticker 0M5A. The last closing price for Kd Dd was 80.00 €. Over the last year, Kd Dd shares have traded in a share price range of 80.00 € to 80.00 €.

Kd Dd currently has 156,000 shares outstanding. The market capitalization of Kd Dd is 12.48 € million. Kd Dd has a price to earnings ratio (PE ratio) of 1.81.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	80	80	80	0	0	DE
4	0	0	80	80	80	0	0	DE
12	0	0	80	80	80	0	0	DE
26	0	0	80	80	80	0	0	DE
52	0	0	80	80	80	0	0	DE
156	0	0	80	80	80	0	0	DE
260	0	0	80	80	80	0	0	DE

0M5A - Frequently Asked Questions (FAQ)

What is the current Kd Dd share price?

The current share price of Kd Dd is 80.00 €

How many Kd Dd shares are in issue?

Kd Dd has 156,000 shares in issue

What is the market cap of Kd Dd?

The market capitalisation of Kd Dd is EUR 12.48M

What is the 1 year trading range for Kd Dd share price?

Kd Dd has traded in the range of 80.00 € to 80.00 € during the past year

What is the PE ratio of Kd Dd?

The price to earnings ratio of Kd Dd is 1.81

What is the cash to sales ratio of Kd Dd?

The cash to sales ratio of Kd Dd is 0.16

What is the reporting currency for Kd Dd?

Kd Dd reports financial results in EUR

What is the latest annual turnover for Kd Dd?

The latest annual turnover of Kd Dd is EUR 79.64M

What is the latest annual profit for Kd Dd?

The latest annual profit of Kd Dd is EUR 6.88M

What is the registered address of Kd Dd?

The registered address for Kd Dd is DUNAJSKA CESTA 63, LJUBLJANA, 1000

What is the Kd Dd website address?

The website address for Kd Dd is www.kd-fd.si

Which industry sector does Kd Dd operate in?

Kd Dd operates in the FINANCE SERVICES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCFTheracryf Plc	0.725p (38.10%)	7.56M
NMTNeometals Ltd	3.50p (27.27%)	346.81k
SCHOScholium Group Plc	44.00p (25.71%)	30.65k
FABFusion Antibodies Plc	10.15p (24.54%)	3.34M
PYXPyx Resources Limited	3.49p (22.24%)	8.43k
TM1Technology Minerals Plc	0.125p (-24.24%)	37.21M
QUIZQuiz Plc	0.70p (-18.60%)	3.67M
SYMESupply@me Capital Plc	0.003p (-17.81%)	168.35M
OBDOxford Biodynamics Plc	1.20p (-14.29%)	827.83k
ZENZenith Energy Ltd.	5.25p (-13.93%)	5.39M
TRPTower Resources Plc	0.0395p (5.33%)	539.51M
CPXCap-xx Limited	0.1825p (1.39%)	494M
NTVONativo Resources Plc	0.0019p (0.00%)	320.16M
DGIDg Innovate Plc	0.0225p (-13.46%)	208.21M
ENETEthernity Networks Ltd	0.1125p (2.27%)	207.56M

Mr. Bill

Mr. Bill 2 minutes ago

https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica

nowwhat2

nowwhat2 4 minutes ago

Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14

https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

DonVance

DonVance 6 minutes ago

This will hit 1k this year I believe now.

georgejjl

georgejjl 7 minutes ago

How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t

Mr. Bill

Mr. Bill 7 minutes ago

Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch

Graniteguy

Graniteguy 8 minutes ago

Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of

BDEZ

BDEZ 10 minutes ago

The Russes hit the jackpot?

BDEZ

BDEZ 11 minutes ago

40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529

BDEZ

BDEZ 12 minutes ago

Not good, thanks for sharing.

sand

sand 19 minutes ago

Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.

mining101

mining101 19 minutes ago

Moving hard soon

mining101

mining101 20 minutes ago

benz280c

benz280c 27 minutes ago

Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.

rx7171

rx7171 34 minutes ago

In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.

TheHound

TheHound 35 minutes ago

Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!

Investor2014

Investor2014 38 minutes ago

When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw

nowwhat2

nowwhat2 44 minutes ago

Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

Because how the overall mkt resolves itself is gonna'r have con

rx7171

rx7171 44 minutes ago

Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca

sunspotter

sunspotter 49 minutes ago

Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.

Investor2014

Investor2014 51 minutes ago

The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.

nowwhat2

nowwhat2 52 minutes ago

Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

Because how the overall mkt resolves itself is gonna'r have con

sunspotter

sunspotter 54 minutes ago

I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.

nowwhat2

nowwhat2 57 minutes ago

Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

Because how the overall mkt resolves itself is gonna'r have con

Invesco Capital Management

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions